Litcius/Paper detail

microRNA‐30a attenuates TGF‐β1–induced activation of pulmonary fibroblast cell by targeting FAP‐α

Geting Wu, Bin Xie, Can Lu, Chen Chen, Jianhua Zhou, Zhenghao Deng

2020Journal of Cellular and Molecular Medicine44 citationsDOIOpen Access PDF

Abstract

Idiopathic interstitial pulmonary fibrosis is a common diffuse interstitial lung disease and has poor prognosis. And one of the pathological features of it is persistent fibroblast activation. It was reported that microRNA-30a was down-regulated in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis patients. But whether miR-30a is involved in fibroblast activation and its specific mechanism is unclear. In this study, we aimed to investigate the role of miR-30a in fibroblast activation induced by TGF-β1. We found miR-30a could targetedly suppress FAP-α expression. In MRC5 cells, miR-30a was not only involved in regulating the expression of FAP-α, col1a and α-SMA induced by TGF-β1 but also had a role in cell proliferation with or without TGF-β1 treatment via regulating FAP-α expression. Thus, the results indicated that miR-30a alleviated fibroblast activation by regulating the expression of FAP-α.

Topics & Concepts

FibroblastPulmonary fibrosisBronchoalveolar lavageIdiopathic pulmonary fibrosisFibroblast activation protein, alphamicroRNATransforming growth factorCancer researchMedicineInterstitial lung diseasePathologicalLungCellFibrosisImmunologyPathologyChemistryBiologyInternal medicineCell cultureCancerGeneBiochemistryGeneticsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPeptidase Inhibition and AnalysisChronic Obstructive Pulmonary Disease (COPD) Research
microRNA‐30a attenuates TGF‐β1–induced activation of pulmonary fibroblast cell by targeting FAP‐α | Litcius